TABLE 2

Difference in EGFR mutations among lung adenocarcinoma patients

Wild-typeDel-19L858RUncommonTotal
Age years
 ≤5068 (42.2)37 (23.0)34 (21.1)22 (13.7)161
 >50298 (33.9)252 (28.7)254 (28.9)74 (8.4)878
Total366 (35.2)289 (27.8)288 (27.7)96 (9.2)1039

Data are presented as n (%) or n. p = 0.043 for lung adenocarcinoma patients aged ≤50 versus >50 years for positive and negative EGFR mutations. p = 0.035 for lung adenocarcinoma patients aged ≤50 versus >50 years with tumours harbouring uncommon EGFR mutations.